The FTC Sued Hims & Hers: What GLP-1 Subscribers Should Check
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
On July 29, 2026, the Federal Trade Commission, joined by California and Utah, sued Hims & Hers over how it bills subscribers and handles their health data. The complaint alleges the company charged people for prescription treatments before a clinician consultation, made refill dates hard to anticipate, buried the cancellation option, and shared sensitive health information with advertising platforms (FTC). These are allegations that a court has not ruled on, and the company disputes them (Hims & Hers). Whoever your provider is, the case points to four things worth checking on your own account.
Who This Helps
This is for anyone who gets a GLP-1 or any prescription through a telehealth subscription, whether or not it is this particular company. The billing and cancellation mechanics described in the complaint are common across the industry, so the checks apply broadly.
What Does the FTC Actually Allege?
The complaint centers on subscription mechanics rather than on the medications themselves. According to the FTC's announcement, the alleged conduct includes charging consumers almost immediately after they submit an intake form, before the promised provider consultation, so that many people were subscribed to a prescription treatment without a chance to review or approve it (FTC).
The other alleged practices, as described by the FTC:
- Refill timing was not clearly disclosed, which made it hard to cancel before the next charge.
- The cancellation option sat behind a menu path about adding or removing items from an order, plus several further steps.
- Sensitive health information was shared with third parties including advertising platforms, despite marketing that emphasized privacy.
Christopher Mufarrige, Director of the FTC's Bureau of Consumer Protection, described the alleged harm as "consumers unknowingly locked into recurring subscriptions and the disclosure to third parties of consumers' most private health information without their consent."
The claims are brought under the FTC Act and the Restore Online Shoppers' Confidence Act, which governs online negative-option billing, along with state consumer-protection laws (FTC).
What Does the Company Say?
Hims & Hers published a response rejecting the FTC's characterization and stating its intention to defend itself (Hims & Hers). Nothing has been decided. A complaint sets out one side's allegations, the defendant answers, and a court or a settlement resolves it later, sometimes years later. Treat the filing as a detailed account of what regulators believe happened, not as an established finding.
What this means for you: we are not telling you to leave this or any provider. The useful move is to verify how your own subscription behaves, because the answers are checkable in a few minutes regardless of how the case ends.
What Should You Check on Your Own Account?
Each of these maps to something the FTC alleged, and each has an answer you can find today.
- 1. When does your next charge hit? Find the actual date, not the interval. If your account only says "monthly," check your card or bank statement for the pattern of past charges, since a charge that lands earlier than you expect is what closes a cancellation window.
- 2. How many steps does cancelling take? Walk the path now without finishing it. If you cannot find a cancellation option in your account settings, note where it actually lives so you are not hunting for it under time pressure.
- 3. Were you charged before you spoke with a clinician? Compare the date of your first charge with the date of your consultation. Keep the record either way.
- 4. What does the privacy policy say about advertising? Search the policy for advertising, analytics, partners, and pixels rather than for the word HIPAA. A company can be subject to HIPAA and still share data with ad platforms, which is why this case was brought under consumer-protection law.
Is This an Isolated Case?
It is the second federal action in this space in under a year. In December 2025 the FTC finalized an order against a different telehealth weight-loss provider over undisclosed costs and membership commitments, unsubstantiated weight-loss claims, fake testimonials and manipulated consumer reviews, unprocessed cancellations, and billing without express informed consent (FTC).
Read together, the two actions describe a pattern in how some subscription health services have operated, and they give you a concrete list of things to look for. The review-manipulation findings in particular are a reason to treat testimonials on any provider's own website as marketing rather than evidence.
What Protections Apply to Subscription Billing?
Online subscriptions are covered by federal rules on negative-option billing, which is the arrangement where your silence is treated as agreement to another charge. Those rules address clear disclosure of terms, obtaining consent before charging, and providing a way to cancel (FTC).
If you believe you were charged without clear consent or could not cancel, you can dispute the charge with your card issuer and file a complaint with the FTC. Keep screenshots of the cancellation flow and your charge dates, because records with screenshots and documentation are far more persuasive than a recollection.
How Should This Change How You Pick a Provider?
Add billing mechanics to the list of things you verify before you enter a card, alongside the checks that were already standard: whether the dispensing pharmacy is licensed in your state, what product you are actually getting, and what the full monthly cost includes.
Our guide to evaluating telehealth and compounded GLP-1 providers walks through the full sequence, and why a pharmacy may not appear licensed in your state covers the verification step people most often get stuck on. If cost is what is pushing you between providers, our look at the GLP-1 price war compares the current cash-pay landscape. You can also compare providers, pricing, and the pharmacies they work with using the GLP Winner provider survey.
Final Takeaway
A federal lawsuit against a large telehealth company put subscription billing and health-data sharing on the record in unusual detail.
None of it is decided. The allegations are serious, the company denies them, and a resolution is likely a long way off.
The part you control is your own account. Know your next charge date, know where the cancel button lives, and know what your provider shares with advertisers.
Those three answers are worth having no matter which provider you use, and no matter what a court eventually concludes here.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Frequently Asked Questions
What did the FTC accuse Hims & Hers of doing?
The FTC, with California and Utah, alleges the company charged consumers for prescription treatments before a clinician consultation, failed to clearly disclose refill timing, made cancellation difficult to find, and shared sensitive health information with advertising platforms. These are allegations and the company disputes them.
Does this lawsuit mean my medication is unsafe?
No. The case concerns billing practices and health-data sharing, not the safety or quality of any medication. Nothing in the complaint alleges the products themselves were harmful.
Should I cancel my telehealth subscription because of this?
That is your decision to make, and this is not advice to leave any provider. The practical step is to verify your own next charge date, your cancellation path, and what your provider shares with advertisers, then decide from there.
What can I do if I was charged without agreeing to it?
You can dispute the charge with your card issuer and file a complaint with the FTC. Save screenshots of the cancellation flow and a record of your charge dates, since documentation created at the time carries more weight.
Does HIPAA stop a telehealth company from sharing my health data with advertisers?
Not necessarily in the way people assume. A company can be subject to HIPAA and still face allegations about sharing information with advertising platforms, which is why this case was brought under consumer-protection law rather than HIPAA. Read the privacy policy for what it says about advertising and analytics.
Sources
Keep Reading
2027 marketplace enrollment runs November 1 to January 15. December 15 is the cutoff for coverage that starts January 1.
Some people split a weekly GLP-1 into two injections. See why, what the pharmacology suggests, the dosing risk, and what to ask your prescriber.
An FDA panel backed 6 of 7 peptides for the compounding list. See the votes, what each was proposed to treat, and what has to happen next.
Categories
Curated by
